Formulation Development and Characterization of Itraconazole Granules
DOI:
https://doi.org/10.37285/ijpsn.2011.4.3.9Abstract
Itraconazole is practically insoluble in water; large inter-individual and intra-individual variations of its oral bioavailability are reported. The main purpose of this study was to prepare and evaluate itraconazole granules for immediate release as drug delivery formulations. As a part of formulation optimization, different concentrations of hydroxy-propyl-methyl cellulose (HPMC) E5 were taken for the preparation of itraconazole granules, and were optimized with different characteristic like size, shape, surface roughness, density, moisture content, assay and dissolution. Formulation optimization includes a detailed study of itraconazole granules with different concentrations of polymer. The results of the study showed that 6% of HPMC E5 is sufficient as a binding agent and gave good shape and surface, low moisture content, 100% assay and 98.24% drug release within one hour. Based on these results, it can be concluded that 6% HPMC E5 is suitable for formulation of itraconazole granules.
Downloads
Metrics
Keywords:
Granules, HPMC E5, itraconazole
Downloads
Published
How to Cite
Issue
Section
References
Amidon GL, Lennernas H, Shah VP and Crison JR (1995). A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413–420.
Aulton ME (2002). Granulation. In Pharmaceutics: The science of dosage form design (Churchill Livingstone, Edinburgh), 2nd edition, pp 181-188.
Conine JW and Hadley HR (1970). Small solid pharmaceutical spheres. Drug Cosmet Ind 90: 38-41.
Gamlen M J (1985). Pellet manufacture for controlled release. Manuf.Chem June, 56-59.
Ghebre S (1989). Mechanism of Pellet Formation and Growth In Pharmaceutical Pelletization Technology (Ghebre-S), Marcel Dekker, Inc., New York, vol. 37 pp 123-143.
Ghebre S, Gordon R, Fawzi MB and Nesbitt RU, (1985). Evaluation of a high-speed pelletization process and equipment. Drug Dev Ind Pharm 11: 1523-1541.
Grant S, Clissold S (1989). Itraconazole: A review of pharmacodynamics and pharmacokinetic properties and therapeutic use in superficial and systemic mycosis. Ind Drugs 37:310-4.
Jackson IM, Roberts S, Timmins P and Sen H, (1989). Comparison of laboratory scale processing in the production of coated pellets. Pharm Technol Int 1: 29-32.
Kristensen J, Schaefer T and Kleinebudde P (2000). Direct pelletization in a rotary processor controlled by torque measurements. II: Effect of changes in the content of microcrystalline cellulose. AAPS Pharm Sci 2(3): 45–52.
Leon L, Herbert AL, Joseph LK, (1991). Tablets, The Theory and Practice of Industrial Pharmacy, Varghese publishing house, Bombay, 3rd edition, pp 318-320.
Niskanen M, (1992). Powder layering and coating in a centrifugal granulator: Effect of binder- solution concentration, powder particle size and coating amount on pellets properties. Doctor’s Thesis, University of Helsinki.
Parikh DM (1997b). High Shear Mixer Granulators. In Handbook of Pharmaceutical Granulation Technology, Marcel Dekker INC, New York.
Parikh DM (1997a). Theory of Granulation. In Handbook of Pharmaceutical Granulation Technology, Marcel Dekker INC, New York.
Patel RP, Patel G and Baria A. (2009) Formulation and evaluation of transdermal patch of Aceclofenac. Int J Drug Deliv 1: 41-51.
Shah A, Shah S, Sheth N and Potdar A (2009). Studies in Optimization of Aqueous Film Coating Parameters. Int J Pharm Sci Nanotech 2(3): 621-626.
Swarbrick J and Boylan JC (1992). Granulation. In Encyclopedia of pharmaceutical technology, Marcel Dekker INC, New York, Vol - 7, pp 121-123.
